publication . Article . Other literature type . 2018

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

Alexander Hein; Melissa Kellar; Jacek Gronwald; Diether Lambrechts; Marc T. Goodman; Michelle A.T. Hildebrandt; Pamela J. Thompson; Malcolm C. Pike; Peter A. Fasching; Peter Hillemanns; ...

View all 129 authors

Open Access English

Published: 21 Aug 2018

Summary
references
16

Abstract

95% CI = 1.03–1.24

doi: 10.3390/ijms19092473 , 10.17863/cam.32437

pmc: PMC6163881

View all 4 identifiers

Subjects

free text keywords: consortia, enolase superfamily member 1, expression quantitative trait locus, genetics, gynecology, ovarian neoplasms, single-nucleotide polymorphism, thymidylate synthase, CANCER ASSOCIATION CONSORTIUM, CARBON TRANSFER PATHWAY, SYNTHASE MESSENGER-RNA, DIFFERENT HISTOTYPES, SUSCEPTIBILITY LOCI, CIGARETTE-SMOKING, GENETIC-VARIATION, METAANALYSIS, EXPRESSION, 3122 Cancers, 1182 Biochemistry, cell and molecular biology, Australian Ovarian Cancer Study Group, Ovarian Cancer Association Consortium, Humans, Adenocarcinoma, Mucinous, Hydro-Lyases, Proteins, RNA, Antisense, Logistic Models, Odds Ratio, Risk, Case-Control Studies, Signal Transduction, Gene Expression Regulation, Neoplastic, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Middle Aged, Female, Genetic Association Studies, Article, Other Chemical Sciences, Other Biological Sciences, Chemical Physics, Biology (General), QH301-705.5, Chemistry, QD1-999, 0399 Other Chemical Sciences, 0604 Genetics, 0699 Other Biological Sciences, /dk/atira/pure/researchoutput/pubmedpublicationtype/D016428, Journal Article, /dk/atira/pure/researchoutput/pubmedpublicationtype/D017418, Meta-Analysis, Consortia, enolase superfamily member 1, expression quantitative trait locus, genetics, gynecology, ovarian neoplasms, single-nucleotide polymorphism, thymidylate synthase, Case-control study, Polymorphism (computer science), Oncology, medicine.medical_specialty, medicine, biology.protein, biology, Adenocarcinoma, medicine.disease, Internal medicine, Expression quantitative trait loci, Ovarian carcinoma

Related Organizations

Medical University of South Carolina
United States
Institute Curie
France
German Cancer Research Centre

Funded by

NIH| Core--Tissue Banking and Pathology, NIH| COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPS, NIH| Life Course Cancer Epidemiology Cohort in Women, NIH| OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS, NIH| Cancer Risk Reduction and Diet: A Cohort Study of Women

Download fromView all 13 versions

HELDA - Digital Repository of the University of Helsinki

Article . 2018

Provider: HELDA - Digital Repository of the University of Helsinki

Europe PubMed Central

Article . 2018

Provider: PubMed Central

eScholarship - University of California

Article . 2018

Provider: eScholarship - University of California

Lirias

Article . 2018

Provider: Lirias

16 references, page 1 of 2

10. Kelemen, L.E.; Goodman, M.T.; McGuire, V.; Rossing, M.A.; Webb, P.M.; Kobel, M.; Anton-Culver, H.; Beesley, J.; Berchuck, A.; Brar, S.; et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1822-1830. [CrossRef] [PubMed] [OpenAIRE]

11. Dolnick, B.J. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. Nucleic Acids Res. 1993, 21, 1747-1752. [CrossRef] [PubMed] [OpenAIRE]

12. Dolnick, B.J.; Black, A.R.; Winkler, P.M.; Schindler, K.; Hsueh, C.T. rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors. Adv. Enzym. Regul. 1996, 36, 165-180. [CrossRef]

13. Chu, J.; Dolnick, B.J. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim. Biophys. Acta 2002, 1587, 183-193. [CrossRef] [OpenAIRE]

14. Vogelstein, B.; Fearon, E.R.; Hamilton, S.R.; Kern, S.E.; Preisinger, A.C.; Leppert, M.; Nakamura, Y.; White, R.; Smits, A.M.; Bos, J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319, 525-532. [CrossRef] [PubMed]

15. Marquez, R.T.; Baggerly, K.A.; Patterson, A.P.; Liu, J.; Broaddus, R.; Frumovitz, M.; Atkinson, E.N.; Smith, D.I.; Hartmann, L.; Fishman, D.; et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin. Cancer Res. 2005, 11, 6116-6126. [CrossRef] [PubMed]

16. Heinzelmann-Schwarz, V.A.; Gardiner-Garden, M.; Henshall, S.M.; Scurry, J.P.; Scolyer, R.A.; Smith, A.N.; Bali, A.; Vanden Bergh, P.; Baron-Hay, S.; Scott, C.; et al. A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br. J. Cancer 2006, 94, 904-913. [CrossRef] [PubMed]

17. Auersperg, N.; Wong, A.S.; Choi, K.C.; Kang, S.K.; Leung, P.C. Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocr. Rev. 2001, 22, 255-288. [CrossRef] [PubMed] [OpenAIRE]

18. Tavassoulu, F.A.; Devilee, P. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs; IARC Press: Lyon, France, 2003.

19. Wang, K.K.; Sampliner, R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008, 103, 788-797. [CrossRef] [PubMed] [OpenAIRE]

20. Pharoah, P.D.; Tsai, Y.Y.; Ramus, S.J.; Phelan, C.M.; Goode, E.L.; Lawrenson, K.; Buckley, M.; Fridley, B.L.; Tyrer, J.P.; Shen, H.; et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat. Genet. 2013, 45, 362-370e2. [CrossRef] [PubMed]

21. Sakoda, L.C.; Jorgenson, E.; Witte, J.S. Turning of COGS moves forward findings for hormonally mediated cancers. Nat. Genet. 2013, 45, 345-348. [CrossRef] [PubMed] [OpenAIRE]

22. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 2015, 348, 648-660. [CrossRef] [PubMed]

23. Konecny, G.E.; Wang, C.; Hamidi, H.; Winterhoff, B.; Kalli, K.R.; Dering, J.; Ginther, C.; Chen, H.W.; Dowdy, S.; Cliby, W.; et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J. Natl. Cancer Inst. 2014, 106. [CrossRef] [PubMed] [OpenAIRE]

24. Higgins, J.P.; Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21, 1539-1558. [CrossRef] [PubMed]

16 references, page 1 of 2

Any information missing or wrong?Report an Issue